Literature DB >> 72336

Propranolol in schizophrenia.

A P Ridges, K Lawton, P Harper, C Ghosh, N Hindson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 72336     DOI： 10.1016/s0140-6736(77)90939-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  [Use of certain cardiological drugs in the treatment of schizophrenia: review of the literature].

Authors:  P M Llorca; M A Wolf
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 2.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

3.  Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.

Authors:  J D Wilson; D J King; B Sheridan
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

4.  Efficacy of propranolol on schizophrenic thought disorder.

Authors:  B B Sethi; S Dube
Journal:  Indian J Psychiatry       Date:  1981-10       Impact factor: 1.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.